Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Cash flows from operating activities:    
Net income (loss) $ (103,959) $ (671,485)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Share-based compensation 22,917 25,311
Depreciation and amortization 2,629 5,323
Amortization of intangible assets 116,086 134,541
Provision for credit loss expense (recovery) 205 275
Provision for (benefit from) income taxes – non-cash (10,270) (43,115)
Non-cash interest expense 1,546 1,550
Non-cash lease and property and equipment impairment charges 4,265 0
(Gain) loss on sale of business 682 (53,756)
Fair value adjustment of warrants (4,750) (26,080)
Impairment of goodwill 0 641,362
Fair value adjustment of hedge instruments (11,186) (5,249)
Change in assets and liabilities, net of effects from acquisitions:    
Right-of-use assets 2,184 4,302
Accounts receivable 70,645 76,821
Prepaid expenses and other current assets 2,726 (617)
Accounts payable (3,283) (3,052)
Accrued expenses and other liabilities, including long-term (20,820) (23,378)
Lease liabilities (3,048) (2,261)
Deferred revenues (75,250) (84,053)
Net cash provided by (used in) operating activities (8,681) (23,561)
Cash flows from investing activities:    
Purchase of property and equipment (3,753) (4,713)
Internally developed software - capitalized costs (8,055) (8,639)
Sale of SumTotal, net of cash transferred (5,137) 171,995
Net cash used in investing activities (16,945) (40,199)
Cash flows from financing activities:    
Shares repurchased for tax withholding upon vesting of restricted stock-based awards (1,441) (2,603)
Payments to acquire treasury stock (8,046) (1,433)
Net cash provided by (used in) financing activities (13,497) 83,690
Effect of exchange rate changes on cash and cash equivalents (1,674) (6,823)
Net increase (decrease) in cash, cash equivalents and restricted cash (40,797) 13,107
Cash, cash equivalents and restricted cash, beginning of period 177,556 168,923
Cash, cash equivalents and restricted cash, end of period 136,759 182,030
Supplemental disclosure of cash flow information:    
Cash and cash equivalents 129,806 174,708
Restricted cash 6,953 7,322
Cash, cash equivalents and restricted cash, end of period 136,759 182,030
Cash paid for interest 50,583 33,490
Cash paid (received) for income taxes, net of refunds 6,262 3,245
Unpaid capital expenditures 0 24
Shares issued in connection with business combination 0 182,550
Accounts Receivable Facility [Member]    
Cash flows from financing activities:    
Proceeds from facility, net of borrowings 793 (33,168)
Term Loan Facility [Member]    
Cash flows from financing activities:    
Proceeds from issuance of debt 0 157,088
Payments on loans (4,803) (36,194)
Codecademy [Member]    
Cash flows from investing activities:    
Acquisition, net of cash received $ 0 $ (198,842)